1. Gasdermin D drives focal crystalline thrombotic microangiopathy by accelerating immunothrombosis and necroinflammation.
- Author
-
Watanabe-Kusunoki K, Li C, Bandeira Honda TS, Zhao D, Kusunoki Y, Ku J, Long H, Klaus M, Han C, Braun A, Mammadova-Bach E, Linkermann A, Van Avondt K, Richter M, Soehnlein O, Linder MI, Klein C, Steiger S, and Anders HJ
- Subjects
- Animals, Humans, Mice, CD18 Antigens metabolism, CD18 Antigens genetics, Disease Models, Animal, Extracellular Traps metabolism, Extracellular Traps immunology, Inflammation pathology, Inflammation metabolism, Interleukin-1beta metabolism, Intracellular Signaling Peptides and Proteins genetics, Intracellular Signaling Peptides and Proteins metabolism, Mice, Inbred C57BL, Mice, Knockout, Pyroptosis, Gasdermins, Neutrophils immunology, Neutrophils metabolism, Neutrophils pathology, Phosphate-Binding Proteins metabolism, Phosphate-Binding Proteins genetics, Thrombotic Microangiopathies pathology, Thrombotic Microangiopathies metabolism, Thrombotic Microangiopathies immunology, Thrombotic Microangiopathies etiology
- Abstract
Abstract: Thrombotic microangiopathy (TMA) is characterized by immunothrombosis and life-threatening organ failure but the precise underlying mechanism driving its pathogenesis remains elusive. In this study, we hypothesized that gasdermin D (GSDMD), a pore-forming protein that serves as the final downstream effector of the pyroptosis/interleukin-1β (IL-1β) pathway, contributes to TMA and its consequences by amplifying neutrophil maturation and subsequent necrosis. Using a murine model of focal crystalline TMA, we found that Gsdmd deficiency ameliorated immunothrombosis, acute tissue injury, and failure. Gsdmd-/- mice exhibited a decrease in mature IL-1β, as well as in neutrophil maturation, β2-integrin activation, and recruitment to TMA lesions, in which they formed reduced neutrophil extracellular traps in both arteries and interstitial tissue. The GSDMD inhibitor disulfiram dose-dependently suppressed human neutrophil pyroptosis in response to cholesterol crystals. Experiments with GSDMD-deficient, human-induced, pluripotent stem cell-derived neutrophils confirmed the involvement of GSDMD in neutrophil β2-integrin activation, maturation, and pyroptosis. Both prophylactic and therapeutic administration of disulfiram protected the mice from focal TMA, acute tissue injury, and failure. Our data identified GSDMD as a key mediator of focal crystalline TMA and its consequences, including ischemic tissue infarction and organ failure. GSDMD could potentially serve as a therapeutic target for the systemic forms of TMA., (© 2024 American Society of Hematology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.)
- Published
- 2024
- Full Text
- View/download PDF